Ceregene
Biotechnology company that treats neurodegenerative disorders using the delivery of nervous system growth factors.
Launch date
Employees
Market cap
-
Enterprise valuation
€42—63m (Dealroom.co estimates Nov 2010.)
San Diego California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$32.0m | Series B | ||
$28.0m | Series C | ||
$11.5m | Series D | ||
N/A | Acquisition | ||
| Total Funding | €65.0m | ||
Related Content
Recent News about Ceregene
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.